POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES (POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES)
**Product type:** Human Prescription Drug
**Active ingredient:** POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS
**Strength:** 236; 2.97; 6.74; 5.86; 22.74 g/274.31g; g/274.31g; g/274.31g; g/274.31g; g/274.31g
**Dosage form:** Powder, For Solution
**Route:** Oral
**Labeler:** Novel Laboratories, Inc.
**Marketing category:** ANDA (ANDA090231)
**Pharmacologic class:** Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
/api/v1/systems/ndc_fda/nodes/40032-090Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.